 Tower Research Capital LLC TRC boosted its holdings in shares of Bellicum Pharmaceuticals Inc NASDAQ:BLCM by 58.1 during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,917 shares of the biopharmaceutical companys stock after purchasing an additional 4,745 shares during the quarter. Tower Research Capital ... 